Meet Inspiring Speakers and Experts at our 3000+ Global Events with over 600+ Conferences, 1200+ Symposiums and 1200+ Workshops on Medical, Pharma, Engineering, Science, Technology and Business.

Explore and learn more about Conference Series LLC Ltd : World’s leading Event Organizer

Conference Series LLC Ltd Conferences gaining more Readers and Visitors

Conference Series LLC Ltd Web Metrics at a Glance

  • 3000+ Global Events
  • 25 Million+ Visitors
  • 25000+ unique visitors per conference
  • 70000+ page views for every individual conference

Unique Opportunity! Online visibility to the Speakers and Experts

copd 2020

About Conference


Conference Series Ltd is overwhelmed to announce the commencement of 10th International Conference on COPD and Lungs” to be held during May 25-26, 2020 in Kyoto, Japan. The upcoming conference will be organized around the theme “Innovative Study on COPD and clinical Research Issues".

COPD 2020 conference brings together individuals who have an interest in the field of Respiratory and Pulmonary Disease relating to diversified topics like COPD, emphysema, asthma, cystic fibrosis, lung cancer, other pulmonary diseases and therapeutics. It is a forum to explore issues of mutual concern as well as exchange knowledge, share evidence and ideas, and generate solutions.

Target Audience:

This event is suited to anyone with an academic or professional interest in COPD and its research; including Researchers, Senior scientists, Pulmonologists, Professors, Doctors, Nurses, Healthcare Professionals, Pharmacologists, Clinicians, Directors of Association and Societies, Postgraduate students and those who work in research and development of pharmaceuticals and related technology

Scope and Importance:

Pulmonary health has a particular interest on the impact changes in respiratory care and the awareness is increasing every year, and therefore COPD 2020 encourages submissions from researchers based in USA, Europe and Asian countries.

The challenge of the field is to evaluate current promising interventions rigorously, address emerging issues such as synthesizing ever-increasing research findings, and develop innovative dissemination and communication strategies.

COPD 2020 provides a platform that helps authors to share their knowledge with a wider audience, and sustains a rapid process for submissions resulting in high quality publications. We further aim to contribute towards reducing the inequity in publications from low- and middle-income countries. Our audience is global and we intend to share research results in COPD from all parts of the world.

Why to Attend?

  • Opportunity to meet world’s Pulmonology Experts
  • Keynote forums by renowned Physicians & Professors
  • Plenary talks and Poster presentations by global experts
  • Best platform for Global business and networking opportunities
  • Oral & Poster presentations by Young Researchers
  • Best poster & Young Research Forum awards

Who to attend?

Faculty Members and Researchers:

  •  Keynote Speech
  •  Plenary Speech
  •  Poster Presentation
  •  Symposium (4-5 member team)        
  •  Workshop

Universities, Associations & Societies:

  •   Association Partnering
  •   Academic Partnering  
  •   Group Participation

Students and Research Scholars:

  •   Poster Competition (Best Poster Award)       
  •   Young Researcher Forum (YRF Award)
  •   Group Participation  

Business Delegates:

  •   Speaker Presentations
  •   Symposium hosting   
  •   Book Launch event   
  •   Networking opportunities      
  •   Audience participation

Product Manufacturers:

  •   Exhibitor and Vendor booths
  •   Sponsorship opportunities
  •   Product launch
  •   Workshop
  •   Scientific Partnering
  •   Marketing and Networking with clients

 

Tracks / Sessions

1. Chronic Obstructive Pulmonary Disease:

Chronic Obstructive Pulmonary Disease (COPD) is an incessant fiery lung ailment that causes blocked wind stream from the lungs. Manifestations incorporate breathing trouble, hack, bodily fluid generation and wheezing. It's brought about by long haul introduction to bothering gases or particulate issue, regularly from tobacco smoke. Individuals with COPD are at expanded danger of creating coronary illness, lung malignant growth and an assortment of different conditions. Emphysema and interminable bronchitis are the two most basic conditions that add to COPD. The aroused bronchial cylinders produce a ton of bodily fluid. This prompts hacking and trouble relaxing. It's portrayed by an everyday hack and bodily fluid generation Chronic Bronchitis.

  • Emphysema
  • Tripod Positioning
  • wheezing

2. Asthma and COPD:

Asthma is one of the ceaseless illnesses including the aviation route in the lungs. This aviation route is called bronchial cylinders; enable air to come all through the lungs. In this asthma condition, your aviation route gets thin and it will deliver additional bodily fluid. With the goal that it can make breathing troublesome and trigger hacking, wheezing and brevity of breath. It tends to be a noteworthy issue that meddles with every day exercises and may prompt a perilous asthma assault. Since asthma frequently changes after some time, it's significant that we have to follow our signs and side effects and modify treatment as required. Asthma determination can likewise be favored consistently so as to standardize the undermining conditions which can be found in the body.

Asthma causes trouble in breathing that frequently results from an unfavorably susceptible response. With regards to COPD both are ceaseless fiery illnesses that incorporate the little aviation route courses and cause wind current obstruction, both outcome from quality condition correspondences and both are commonly described by bodily fluid and bronchoconstriction.

Asthma prescription consistently has a key impact in how well you control your condition. Controller pharmaceuticals are the most fundamental since they turn away asthma attacks. When you use these meds, your flight courses are not so much exasperated but rather more loath to react to triggers. On the off chance that you have to use a defend sedate multiple times each week, your asthma isn't particularly controlled. The right pharmaceutical should empower you to continue with a working and normal life.

  • Allergy Induced Asthma
  • Diagnosis and Prevention
  • Breathing Difficulty
  • Stress

3. Lung Cancer:

Lung malignant growth is a sort of disease that starts in the lungs. Your lungs are two springy organs in your chest that take in oxygen when you breathe in and discharge carbon dioxide when you breathe out. Individuals who smoke have the most serious danger of lung malignant growth; however lung disease can likewise happen in individuals who have never smoked. The danger of lung malignant growth increments with the period of time and the quantity of cigarettes you've smoked.

  • Mesothelioma
  • Squamous cell carcinomas
  • Large cell carcinoma
  • Undifferentiated non-small cell lung cancer
  • Adenocarcinomas

4. Epidemiology of COPD:

Constant obstructive aspiratory illness (COPD) is in charge of early mortality, high demise rates and noteworthy expense to wellbeing frameworks. Dynamic smoking remains the principle hazard factor, however different variables are winding up better referred to, for example, word related elements, contaminations and the job of air contamination. Predominance of COPD fluctuates as per the nation, age and sex. This malady is additionally connected with critical comorbidities. COPD is a confusion that incorporates different phenotypes, the continuum of which stays under discussion. The real challenge in the coming years will be to anticipate the beginning of smoking alongside early discovery of the malady in the overall public. This may speak to weakening in the patient's premorbid condition with the end goal that hypoxemia exacerbates and hypercapnia creates during a moderately inconsequential respiratory tract contamination, which might be viral or bacterial.

  • Smoking
  • Air Pollution
  • Occupational Factors
  • Short of Breath

5. Pediatric Pulmonology:

Incessant pneumonic issue is a central hazard issue of youngsters' passing. The arrangement of concentrates on pediatric aspiratory issue indicates covering age groups from birth to late middle age that early life occasion which incorporates pre-birth impacts on lung development and plans the tyke at expanded hazard for future COPD. A few signs are mucus creation, incessant hack, visit lung diseases, and issue doing day by day exercises due to shortness of breath. Pediatric pulmonology depends on finding, treatment, and achieve youngsters from birth to 21 years of age with breathing and lung illnesses. The COPD issue in newborn children equivalent pneumonia, asthma, tuberculosis, muddled chest contaminations are relieved pediatric pulmonologists

  • Dysplasia
  • Interstitial lung disease
  • Cystic fibrosis
  • Recurrent aspiration

6. Pulmonary Hypertension:

Aspiratory hypertension is a sort of hypertension that bothers the supply routes in the lungs and the correct side of the heart. These are the genuine situations that turned out to be dynamically more regrettable and are incidentally lethal. These vacillations can reason the dividers of the supply routes to turn out to be thick and hardened, and additional tissue may shape. The veins can likewise end up aggravated and tight. The indications are arranged by chest torment, swelling in lower legs, legs. Albeit a few courses of action of aspiratory hypertension aren't reparable, treatment can help diminish side effects and improve the predominance of life. Additionally, pregnancy may have astute dangers for ladies with aspiratory hypertension, so make certain to talk about conception prevention choices with the doctor.

  • Gene mutation
  • Congenital heart disease
  • Arrhythmia
  • Angina
  • Liver disease

7. Respiratory Diseases:

Respiratory infections are the normal and significant reason of sickness and passing around the world. In the UK, around 1 out of 7 people are influenced by some class of interminable lung ailment. Individuals with respiratory infection experience difficulty breath from a restriction in preparing freshen up of lungs which further can cause emphysema and incessant bronchitis. The tissues and organs that make trade of gas likely in higher living beings, and incorporates states of trachea, bronchi, upper respiratory tract, bronchioles, alveoli, pleura and pleural pit, and the nerves and muscles of breathing happens if there should arise an occurrence of uncontrolled circumstances. They are portrayed by a high fiery cell enlistment or damaging cycle of disease. Probably the most widely recognized are asthma, incessant obstructive aspiratory ailment, and pneumonic emanation. As CRDs are not remediable; in any case, different types of treatment that help enlarge significant air sections and improve brevity of breath can bolster control manifestations and increment the personal satisfaction for individuals with the infections.

  • Acute respiratory distress syndrome
  • Respiratory failure
  • Hypersensitivity pneumonitis
  • Pulmonary fibrosis
  • Upper Respiratory tract infections

8. COPD and Cardiovascular Diseases:

Constant obstructive pneumonic sickness is related with an expanded possibility of cardiovascular ailment, for example, heart disappointment or a heart assault. The lungs and the heart work steadily together to supply the oxygen; oxygen noticeable all around comes into the lungs is moved into the dissemination framework, which the heart by then motivations out to rest of the body. However, illnesses in both the heart and the lungs routinely go together. On the off chance that any individual has COPD by then, there is a higher danger of having cardiovascular infections. Comorbidities and incessant obstructive aspiratory infection (COPD) are all inclusive, with cardiovascular ailment being the most striking and noteworthy. COPD Conferences will concentrate on the extent of COPD related with cardiovascular infections.

9. Drug Discovery of COPD:

COPD is one of the most public infections on the planet, and there is a worldwide increment in event, yet there are no medications accessible at present that end the unremitting movement of this malady. In any case, a superior comprehension of the cell and atomic instruments that are engaged with the basic incendiary and dangerous procedures has uncovered a few new objectives for which medications are currently being developed, and the prospects for finding new medicines are great. By and large, Lung Conferences will concentrate on the various procedures utilized in pulmonology.

10. Genetic Risk Factor of COPD:

Regardless of whether an individual has never smoked or been helpless to poisons for an all-inclusive period, they can even now advance COPD. Alpha-1 Antitrypsin Deficiency (AATD) is the most habitually realized inherited peril factor of COPD in emphysema. Alpha-1 Antitrypsin related COPD is brought about by the characteristic lack of the Alpha-1 in the circulatory framework. Without the Alpha-1 Antitrypsin protein, white platelets in blood begin to hurt the lungs and lung decay happens. The World Health Organization and the American Thoracic Society suggests that each individual unflinching to have COPD be tried for Alpha-1. All the Pulmonology Conferences additionally talks about various classifications of qualities which might be a reason for aspiratory maladies.

11.Tuberculosis and COPD:

Tuberculosis and Chronic Obstructive Pulmonary Disease pass on about a critical worry as far as bleakness and mortality everywhere throughout the world. This focus on different bits of tuberculosis to the extent the relationship with COPD, for example, in the progression of constant wind current deterrent as a result of dynamic tuberculosis and evaluating the key hero of cigarette smoking in the pathogenesis of the two conditions. Patients resolved to have tuberculosis may normally have broad co-dreariness, for example, COPD and the effect of a hidden determination of COPD on results in tuberculosis is likewise inspected. COPD Conferences investigates all the new thoughts and procedures of aspiratory treatment.

  • Airway obstruction
  • Genetic Vulnerability
  • Common Risk factors

12. Lung Diseases:

Lung maladies are clutters or contaminations that influence the lungs and cause breathing issues. Some can prompt respiratory disappointment. The term lung ailment alludes to numerous clutters influencing the lungs, for example, asthma, COPD, contaminations like flu, pneumonia and tuberculosis, lung malignant growth, and numerous other breathing issues. Some lung illnesses can prompt respiratory disappointment.

  • Allergic Asthma
  • Diaphragmatic Breathing
  • Acute Respiratory Tract Infection
  • Acute Respiratory Distress Syndrome
  • Sinusitis

13. Pneumonia and COPD:

Individuals who are experiencing COPD will presumably make pneumonia. Pneumonia is especially dangerous for people with COPD by causing an expanded danger of respiratory disappointment. This is the reality at which your body is either not getting enough oxygen or isn't successfully removing carbon dioxide. Pneumonia and COPD can bring about genuine confusions. Long haul and even perpetual harm can happen. Early treatment can help decline these dangers. The irritation from pneumonia can compel your wind stream, which can further harm your lungs. This can advance into intense respiratory disappointment, which can be deadly. COPD Conferences edify the ongoing advances in COPD and pulmonology inquire about.

  • Epidemiology
  • Pathogenesis

14. Advanced Respiratory Disease Treatment:

As of now, patients with Respiratory illnesses utilize various gadgets, which help the subtraction of bodily fluid from the Airways and the improvement of aspiratory work. Dreary respiratory organ achieves, and digestion muscle testing is prescribed in youths with Neuromuscular Disease, be that as it may, these preliminaries are kept up non-obtrusive willful man oeuvres, similar to the estimating of respiratory organ volumes and incomparable static weights, which youthful adolescents may not perpetually have the option to accomplish. Essentially, before the treatment Observation digestion muscles in youths with NMD may propel comprehension of the clarification of NMD and thusly the examination of disorder seriousness. Presently, gadgets appear to expand patients' consistence with customary treatment, since they present much help, as an autonomous application, full control of treatment and simple use.

  • Lung Transplantation in Cystic Fibrosis
  • Positive Airway Pressure Therapy
  • Physiotherapy
  • Physical Examination

15. Idiopathic Pulmonary Fibrosis:

Idiopathic aspiratory fibrosis (IPF) is a sort of lung illness that outcomes in scarring (fibrosis) of the lungs for a unidentified reason. After some time, the scarring deteriorates and it turns out to be difficult to take in an incomprehensible breath and the lungs can't take in enough oxygen. IPF is a type of interstitial lung sickness, principally relating the interstitial (the tissue and space around the air sacs of the lungs), and not right influencing the aviation routes or veins. There are numerous different kinds of interstitial lung illness that can likewise reason irritation as well as fibrosis, and these are dealt with conversely.

16: Pathophysiology of COPD:

Fundamentally, the pathophysiology of COPD is quickly unveiling. There will be some physiological modification which ultimately impacts the quality of life and survival in the natural progress of COPD when the pathological significances of the COPD inflammation induce a sequence of physiological changes. Fibrotic remodeling of the airways results in fixed airway narrowing initiating increased airway resistance which does not completely revert even with bronchodilators. Emphysema also decreases lung elastic recoil pressure which leads to a reduced driving pressure for expiratory flow through narrowed and poorly supported airways in which airflow resistance is significantly increased.

  • Antitrypsin Deficiency
  • Bronchial Hyper reactivity
  • Tachypnea

17. Pulmonary Rehabilitation:

Comprehensive pneumonic recovery is an imperious piece of the clinical supervision of individuals with interminable obstructive aspiratory sickness (COPD). Aspiratory recovery is a program of dynamic exercise and instruction regulated by a physiotherapist for people with COPD. In the investigation of aspiratory restoration, you will likewise find out about the breathing methods, prescriptions, legitimate nourishment for COPD patients, unwinding, oxygen, travel, how to do normal endeavors with less brevity of breath. Lung Conferences gives a worldwide gathering to talk about the development of pulmonology inquire about.

18. Stages of Asthma:

Stage 1 or discontinuous asthma: This gathering of kids has side effects close to two times each week, don't have issues in the middle of flare-ups, and just have short flare-ups from a couple of hours to a couple of days. Evening time side effects happen under two times each month.

Stage 2 or mellow relentless: This gathering of kids has manifestations multiple times each week, however not day by day, and may have movement levels influenced by the flare-ups. Evening side effects happen more prominent than two times each month, however close to once every week.

Stage 3 or moderate determined: This gathering of youngsters has side effects each day, utilize their salvage medicine each day and may have action levels influenced by the flare-ups. Evening manifestations happen more prominent than one time seven days.

Stage 4 or extreme constant: This gathering of youngsters has indications on numerous occasions every day, have a diminishing in their physical action and have continuous flare-ups. Evening side effects happen much of the time.

  • Mild Intermittent Asthma
  • Mild Persistent Asthma
  • Moderate Persistent Asthma
  • Severe Persistent Asthma

 

Market Analysis

Major COPD Research Associations around Asia Pacific

COPD Patient Organization of Vietnam

COPD Patients Club Kyrgyzstan

COPD Club of Northern Thailand

Asian Pacific Society of Respirology

Chinese COPD Patient Education Organziation

Major COPD Research Associations around Globe

Alpha-1 Foundation

American Association for Respiratory Care

American College of Chest Physicians

American College of Emergency Physicians

American College of Physicians

American Lung Association

Canadian Lung Association (CLA)

COPD Foundation

Target Audience:

• Directors, Board Members, Presidents, Vice Presidents, Deans and Head of the Departments

• COPD Students, Scientists, Faculty

• Medical Colleges

• COPD Associations and Societies

• Business Entrepreneurs, Pharmaceutical companies

Universities Associated with COPD 2017

Major Universities on COPD Research

Kumamoto University, Japan

Tokyo National Hospital, Japan

KindaiUniversity, Japan

Okayama University, Japan

Medi7 Bentleigh, Australia

Macquarie University, Australia

Australian national university, Australia

Charles Darwin University Casoria Australia

Curtin University Bentley, Australia

Dar Al Uloom University, Saudi Arabia

Iqbal Chest Centre, Bangladesh

Imperial College London, United Kingdom

Linnaeus University, Sweden

University Of California Los Angeles, United States

Columbia University Medical Center, United States

Harvard University, United States

Global Market research on COPD

The global COPD market is estimated to currently be worth $11.3 billion, and is forecast to reach

a value of $15.6 billion by 2019. The drugs driving this growth include once-daily LABA/LAMA

fixed-dose combinations such as QVA-149, umeclidinium bromide/vilanterol and olodaterol/tiotropium.

The opportunity in the U.S. and China asthma and COPD drugs market is slated to rise from a valuation of US$13.0 bn in 2015 to be worth US$18.7 bn by 2024. If these values hold true, the market is likely to expand at a modest CAGR of 4.1% therein.

North America leads the global market for asthma &COPD drugs and devices. North America was followed by Europe in terms of market capitalization. Asia Pacific is expected to be the fastest regional market for asthma and COPD owing to the increased incidence of asthma & other respiratory diseases in industrial regions.

The current asthma and COPD market is primarily driven by increasing patient population. It is also growing due to factors such as price erosion and expiry of patents of leading drug brands in the market. However, it is estimated that in the next five years, the global asthma and COPD drug market is expected to grow slowly and steadfast. The COPD segment was projected to be worth USD 10,593.2 million and is expected to reach USD 12,619.8 million in 2017.

In Europe, LABA / ICS combinations and LTA (Montelukast) drugs are more popular for asthma and COPD treatment.

Top few companies in this global market:

AstraZeneca

GlaxoSmithKline

F. Hoffmann-La Roche

Novartis and Merck

Abbott

Amgen

Actavis

Boehringer Ingelheim

Cipla

Glenmark

Pfizer

Ranbaxy

Sunovion

Vectura

Global COPD & Asthma Devices Market, By Product

Inhalers

Nebulizers

Inhalers accounted for the major market and is expected to continue its dominance till 2020

Global COPD & Asthma Devices Market, By Geography

North America

Europe

Asia-Pacific

LAMEA

LAMEA region would exhibit the highest CAGR of 4.9% during 2017-2020

Past Conference Report

COPD 2019

Conference series LLC Ltd successfully hosted for "9th International Conference on COPD and Lungs" during August 19-20, 2019, Tokyo, Japan. COPD 2019 conference was organized around the theme "Every breath counts: Halt the rise of COPDand it was a great success where eminent keynote speakers from various reputed organizations made their resplendent presence and addressed the gathering.

COPD 2019 was marked by the attendance of Editorial Board Members of supported Journals like Journal of Pulmonary & Respiratory Medicine, Journal of Lung Diseases & Treatment and Journal of Pulmonary Medicine. Many Scientists, young and brilliant Researchers, Business Delegates and talented Student Communities representing from varies countries made this conference fruitful and productive driving the three-day event into the path of success with thought provoking keynote and plenary presentations.

9th International Conference on COPD and Lungs covered the following scientific sessions and discussions:

Chronic Obstructive Pulmonary Disease

Respiratory Diseases

Pneumonia and COPD

Asthma and COPD

COPD and Cardiovascular Diseases

Advanced Respiratory Disease Treatment

Lung cancer

Drug Discovery of COPD

Idiopathic Pulmonary Fibrosis

Epidemiology of COPD

Genetic Risk Factor of COPD

Pathophysiology of COPD

Pediatric Pulmonology

Tuberculosis and COPD

Pulmonary Rehabilitation

Pulmonary Hypertension

Lung Diseases

Stages of Asthma

COPD 2019 Organizing Committee would like to thank the Moderator of the conference.

Heru Wiyono

Persahabatan Hospital, Indonesia

With the feedback from the participants and supporters of COPD 2019, Conference series LLC Ltd is glad to announce 10th International Conference on COPD and Lungs (COPD 2020) during May 25-26, 2020 in Kyoto, Japan. COPD 2020 will cover some of the most challenging topics and advancements in research in the fields of Pulmonary and Respiratory medicine.

 

 


Past Reports  Gallery  

To Collaborate Scientific Professionals around the World

Conference Date May 25-26, 2020

For Sponsors & Exhibitors

[email protected]

Speaker Opportunity

Past Conference Report

Supported By

Journal of Pulmonary & Respiratory Medicine Journal of Lung Diseases & Treatment Journal of Lung

All accepted abstracts will be published in respective Conference Series LLC LTD International Journals.

Abstracts will be provided with Digital Object Identifier by